Related Experiment Video
Updated: Aug 7, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Neoadjuvant Therapy for Melanoma
Margaret H O'Connor1, Isabel DeLaura2, Georgia M Beasley1
1Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Advances in Surgery
|August 5, 2026
Summary
Neoadjuvant immunotherapy, using immune checkpoint inhibitors, enhances the immune system to target melanoma cells before surgery. This approach improves survival rates and reduces recurrence by treating occult disease and allowing pathologic response assessment.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Immune checkpoint inhibitors (ICIs) and targeted therapies have revolutionized cancer treatment.
- Neoadjuvant therapy, administered before definitive treatment, is an evolving strategy in oncology.
- Melanoma treatment has seen significant advancements with novel therapeutic agents.
Purpose of the Study:
- To evaluate the efficacy of neoadjuvant immunotherapy in melanoma treatment.
- To explore the benefits of pre-operative immunotherapy for immune system enhancement against melanoma.
- To assess the impact of neoadjuvant immunotherapy on survival rates and recurrence.
Main Methods:
- Administration of immune checkpoint inhibitors and targeted therapies in the neoadjuvant setting.
- Utilizing neoantigens to enhance the immune response against melanoma cells.
- Pathologic assessment of treatment response post-neoadjuvant therapy.
Main Results:
- Neoadjuvant immunotherapy enhances the immune system's ability to target melanoma cells.
- Pre-operative immunotherapy aids in treating clinically occult and metastatic melanoma.
- Pathologic assessment of response correlates with improved survival and reduced recurrence.
Conclusions:
- Neoadjuvant immunotherapy is a promising strategy for melanoma, improving outcomes.
- This approach allows for early assessment of treatment efficacy.
- Further clinical trials are needed to optimize treatment duration, choice, and strategies.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...